Ipsen Biopharm Ltd

About Ipsen Biopharm Ltd

Ipsen Biopharm Ltd is a global biopharmaceutical group focused on innovation and specialty care. Established in the UK, the company is dedicated to improving patients’ lives through the development of innovative medicines. With a strong emphasis on research and development, Ipsen aims to address unmet medical needs in various therapeutic areas, including oncology, neurology, and endocrinology.

The company operates with a commitment to high-quality standards and ethical practices, ensuring that all products meet rigorous safety and efficacy requirements. Ipsen’s portfolio includes a range of proprietary and partnered products, showcasing its dedication to advancing healthcare solutions.

In addition to its robust product pipeline, Ipsen invests significantly in scientific research and collaborations with leading academic institutions and industry partners. This collaborative approach fosters innovation and accelerates the development of new therapies.

With a presence in over 100 countries, Ipsen Biopharm Ltd is well-positioned to make a global impact. The company’s mission is to provide patients with access to cutting-edge treatments while maintaining a focus on sustainability and corporate responsibility.

As part of its vision, Ipsen strives to be a leader in the biopharmaceutical industry, continuously seeking ways to enhance patient outcomes and contribute to the advancement of medical science.

• Core Areas: Oncology, Neurology, Endocrinology
• Global Reach: Operations in over 100 countries
• Commitment: Innovation, Quality, Sustainability